产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
A998803 | Anti-IGF1R / CD221 Reference Antibody (dalotuzumab), Anti-IGF1R / CD221 Reference Antibody (dalotuzumab), |
|||
A998804 | Anti-IGF1R / CD221 Reference Antibody (figitumumab), Anti-IGF1R / CD221 Reference Antibody (figitumumab), |
|||
A998805 | Anti-IGF1R / CD221 Reference Antibody (ganitumab), Anti-IGF1R / CD221 Reference Antibody (ganitumab), |
|||
A998806 | Anti-IGF1R / CD221 Reference Antibody (Immunomedics patent anti-IGF-1R), Anti-IGF1R / CD221 Reference Antibody (Immunomedics patent anti-IGF-1R), |
|||
A998807 | Anti-IGF1R / CD221 Reference Antibody (lonigutamAb), Anti-IGF1R / CD221 Reference Antibody (lonigutamAb), |
|||
A998808 | Anti-IGF1R / CD221 Reference Antibody (robatumumab), Anti-IGF1R / CD221 Reference Antibody (robatumumab), |
|||
A998809 | Anti-IGF1R / CD221 Reference Antibody (teprotumumab), Anti-IGF1R / CD221 Reference Antibody (teprotumumab), |
|||
A998810 | Anti-IGF2 Reference Antibody (DX-2647), Anti-IGF2 Reference Antibody (DX-2647), |
|||
A998811 | Anti-IL-10 Reference Antibody (BT-063), Anti-IL-10 Reference Antibody (BT-063), |
|||
A998812 | Anti-IL-12 (IL-12a & IL-12b) Reference Antibody (briakinumab), Anti-IL-12 (IL-12a & IL-12b) Reference Antibody (briakinumab), |
|||
A998813 | Anti-IL-12b Reference Antibody (ebdarokimab), Anti-IL-12b Reference Antibody (ebdarokimab), |
|||
A998814 | Anti-IL-13 Reference Antibody (abrezekimab), Anti-IL-13 Reference Antibody (abrezekimab), |
|||
A998815 | Anti-IL-13 Reference Antibody (anrukinzumab), Anti-IL-13 Reference Antibody (anrukinzumab), |
|||
A998816 | Anti-IL-13 Reference Antibody (cendakimab), Anti-IL-13 Reference Antibody (cendakimab), |
|||
A998817 | Anti-IL-13 Reference Antibody (CNTO 607), Anti-IL-13 Reference Antibody (CNTO 607), |
|||
A998818 | Anti-IL-13 Reference Antibody (dectrekumab), Anti-IL-13 Reference Antibody (dectrekumab), |
|||
A998819 | Anti-IL-13 Reference Antibody (GSK 679586), Anti-IL-13 Reference Antibody (GSK 679586), |
|||
A998820 | Anti-IL-13 Reference Antibody (H2L6), Anti-IL-13 Reference Antibody (H2L6), |
|||
A998821 | Anti-IL-13 Reference Antibody (IMA-026), Anti-IL-13 Reference Antibody (IMA-026), |
|||
A998822 | Anti-IL-13 Reference Antibody (lebrikizumab), Anti-IL-13 Reference Antibody (lebrikizumab), |